Press Room MediaRoom Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA Mon, 26 Sep 2016 06:48:00 -0400 Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform - Joshua Riff, M.D., Named Chief Executive Officer - Mon, 12 Sep 2016 08:04:00 -0400 Sanofi Announces Q2 2016 Results Fri, 29 Jul 2016 08:00:00 -0400 Sanofi Receives FDA Approval of Adlyxin™ for Treatment of Adults with Type 2 Diabetes - Adlyxin™ is approved as Lyxumia® in more than 60 countries - Wed, 27 Jul 2016 20:12:00 -0400 Surveys Find Adults with Type 2 Diabetes Are More Willing to Take Action to Achieve A1C Targets Quicker than Physicians and Other Medical Professionals Perceive -- Findings reveal that some patients are frustrated and discontinued medication because they were not reaching their individualized A1C target quick enough -- Wed, 20 Jul 2016 09:05:00 -0400